Article révisé par les pairs
Titre:
  • Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.
Auteur:Lin, Nancy U; Diéras, Véronique; Paul, Devchand; Lossignol, Dominique; Christodoulou, Christos; Stemmler, Hans-Joachim; Roche, Henri; Liu, Cindy Meng Hsin; Greil, R.; Ciruelos, Eva; Loibl, Sibylle; Gori, Stefania; Wardley, Andrew; Yardley, Denise; Brufsky, Adam; Blum, J.; Rubin, Stephen D; Dharan, Bernie; Steplewski, Klaudia; Zembryki, Denise; Oliva, Cristina; Roychowdhury, Debasish; Paoletti, Paolo; Winer, Eric P
Informations sur la publication:Clinical cancer research, 15, 4, page (1452-1459)
Statut de publication:Publié, 2009-02
Sujet CREF:Cancérologie
MeSH keywords:Adult
Aged
Aged, 80 and over
Antineoplastic Agents -- therapeutic use
Brain Neoplasms -- drug therapy -- mortality -- secondary
Breast Neoplasms -- pathology
Deoxycytidine -- administration & dosage -- analogs & derivatives
Female
Fluorouracil -- administration & dosage -- analogs & derivatives
Humans
Middle Aged
Prospective Studies
Protein Kinase Inhibitors -- therapeutic use
Quinazolines -- administration & dosage -- adverse effects -- therapeutic use
Receptor, erbB-2 -- analysis -- antagonists & inhibitors
Note générale:Clinical Trial, Phase II
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:1078-0432
info:doi/10.1158/1078-0432.CCR-08-1080
info:pii/15/4/1452
info:pmid/19228746

Documents en relation

DI-fusion